foxo4-dri human clinical trial peptide senolytic Molecular modelling of the FOXO4-TP53 interaction to design senolytic FOXO4-DRI improves spermatogenesis in aged
Description
All references are limited exclusively to controlled laboratory research environments
Parkhitko, A
worked with daily injections of 50 mg (which are extremely high doses)
But these aren't approved medical uses
0.3 mL Syringe(showing per shot 2 shots total) 25 IU Tips & Notes Mechanism 5-Amino-1MQ inhibits NNMT, an enzyme overexpressed in fat tissue
